[HTML][HTML] Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

HC Sun, J Zhou, Z Wang, X Liu, Q Xie… - … surgery and nutrition, 2022 - ncbi.nlm.nih.gov
Recent advances in systemic and locoregional treatments for patients with unresectable or
advanced hepatocellular carcinoma (HCC) have resulted in improved response rates. This …

[HTML][HTML] Current and future treatment of hepatocellular carcinoma: an updated comprehensive review

S Daher, M Massarwa, AA Benson… - Journal of clinical and …, 2018 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …

[HTML][HTML] Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)

J Zhou, H Sun, Z Wang, W Cong, J Wang, M Zeng… - Liver cancer, 2020 - karger.com
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the
fourth most common malignancy and the second leading cause of tumor-related death …

Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition)

J Zhou, HC Sun, Z Wang, WM Cong, JH Wang… - Liver cancer, 2018 - karger.com
Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …

[HTML][HTML] Treatment strategies for hepatocellular carcinoma—a multidisciplinary approach

I Lurje, Z Czigany, J Bednarsch, C Roderburg… - International journal of …, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and its
mortality is third among all solid tumors, behind carcinomas of the lung and the colon …

Standard for diagnosis and treatment of primary liver cancer (2022 edition)

General Office of National Health Commission - 临床肝胆病杂志, 2022 - lcgdbzz.org
Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …

[HTML][HTML] Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma

A Lauterio, R De Carlis, L Centonze, V Buscemi… - Cancers, 2021 - mdpi.com
Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition)

J Zhou, H Sun, Z Wang, W Cong, M Zeng, W Zhou… - Liver Cancer, 2023 - karger.com
Background: Primary liver cancer, of which around 75–85% is hepatocellular carcinoma in
China, is the fourth most common malignancy and the second leading cause of tumor …

[HTML][HTML] New frontiers in liver resection for hepatocellular carcinoma

M Allaire, C Goumard, C Lim, A Le Cleach, M Wagner… - JHEP Reports, 2020 - Elsevier
Liver resection is one of the main curative options for early hepatocellular carcinoma (HCC)
in patients with cirrhosis and is the treatment of choice in non-cirrhotic patients. However …

The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review

GK Glantzounis, E Tokidis, SP Basourakos… - European Journal of …, 2017 - Elsevier
Background Primary liver and biliary cancers are very aggressive tumors. Surgical treatment
is the main option for cure or long term survival. The main purpose of this systematic review …